Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02837536 · ClinicalTrials.gov registry record · NA

Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings

A NA study of Intraocular Pressure, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
107
Enrollment target
1
Study location

NCT02837536 is a NA study of Intraocular Pressure that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 107 participants, above the 76-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (41% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02837536, a NA study of Intraocular Pressure, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
107 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to evaluate the agreement between intraocular pressure (IOP) measurements taken by iCare, held in both vertical and horizontal positions. In addition, iCare measurements will be compared against pneumotonometry measurements to assess for accuracy.

Conditions Studied

Interventions

  • OTHER Horizontal iCare
  • OTHER Vertical iCare

Study Locations (1)

Texas

  • Robert Cizik Eye Clinic - Houston

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2016-06-23
Est. Completion 2016-12-23
Phase NA

What the Registry Record Tells You About NCT02837536

The ClinicalTrials.gov registry entry for NCT02837536 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 76-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (41% higher). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intraocular Pressure appearing as the primary indexed condition, and to 2 interventions - of which Horizontal iCare is the first listed.

NCT02837536 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02837536 about?

NCT02837536 is a clinical study titled "Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings". The goal of this study is to evaluate the agreement between intraocular pressure (IOP) measurements taken by iCare, held in both vertical and horizontal positions. In addition, iCare measurements will be compared against pneumotonometry measurements to assess for accuracy.

What is the current status of trial NCT02837536?

This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2016-06-23. Estimated completion is 2016-12-23.

What conditions does trial NCT02837536 study?

This clinical trial studies the following conditions: Intraocular Pressure.

What interventions are being tested in trial NCT02837536?

The interventions under investigation include: Horizontal iCare (OTHER), Vertical iCare (OTHER).

Who is sponsoring clinical trial NCT02837536?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02837536 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intraocular Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.